Omega-3 and omega-6 fatty acid concentrations in red blood cell membranes relate to schizotypal traits in healthy adults

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 69, Issue 6, 2003, Pages 461-466

  Richardson, A J ^a   Cyhlarova, E ^a   Ross, M A ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Omega 3 fatty acids; Omega 6 fatty acids; Red blood cell membrane; Schizophrenia; Schizotypy

Indexed keywords

ADRENIC ACID; ARACHIDONIC ACID; DOCOSAPENTAENOIC ACID; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID;

ADULT; ARTICLE; CELL LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; ERYTHROCYTE MEMBRANE; FEMALE; GAS LIQUID CHROMATOGRAPHY; HUMAN; LIPID COMPOSITION; MALE; PRIORITY JOURNAL; SCHIZOTYPAL PERSONALITY DISORDER;

EID: 0344873190     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.plefa.2003.08.018     Document Type: Article

References (21)

1. A.I. Glen, E.M. Glen, D.F. Horrobin, K.S. Vaddadi, M. Spellman, N. Morse Fisher, K. Ellis, F.S. Skinner, A red cell membrane abnormality in a subgroup of schizophrenic patients: evidence for two diseases, Schizophr. Res. 12 (1994) 53-61.
2. M. Peet, J.D. Laugharne, J. Mellor, C.N. Ramchand, Essential fatty acid deficiency in erythrocyte membranes from chronic schizophrenic patients, and the clinical effects of dietary supplementation, Prostaglandins Leukot. Essent. Fatty Acids 55 (1996) 71-75.
3. W.S. Fenton, J. Hibbeln, M. Knable, Essential fatty acids, lipid membrane abnormalities, and the diagnosis and treatment of schizophrenia, Biol. Psychiatry 47 (2000) 8-21.
4. D.F. Horrobin, Schizophrenia as a prostaglandin deficiency disease, Lancet 1 (1977) 936-937.
5. D.F. Horrobin, A.I. Glen, K. Vaddadi, The membrane hypothesis of schizophrenia, Schizophr. Res. 13 (1994) 195-207.
6. D.F. Horrobin, Schizophrenia: the illness that made us human, Med. Hypotheses 50 (1998) 269-288.
7. M. Peet, I. Glen, D.F. Horrobin, Phospholipid Spectrum Disorder in Psychiatry, Marius Press, Carnforth, 1999.
8. M. Peet, J. Brind, C.N. Ramchand, S. Shah, G.K. Vankar, Two double-blind placebo-controlled pilot studies of eicosapentaenoic acid in the treatment of schizophrenia, Schizophr. Res. 49 (2001) 243-251.
9. M. Peet, D.F. Horrobin, E-E-Multicentre-Study-Group. A dose-ranging exploratory study of the effects of ethyl-eicosapentaenoate in patients with persistent schizophrenic symptoms. J. Psychiatr. Res. 36 (1) (2002) 7-18.
10. J.A. Stanley, In vivo magnetic resonance spectroscopy and its application to neuropsychiatric disorders, Can. J. Psychiatry 47 (2002) 315-326.
11. H. Fukuzako, S. Kodama, T. Fukuzako, Phosphorus metabolite changes in temporal lobes of subjects with schizotypal personality disorder, Schizophr. Res. 58 (2002) 201-203.
12. A.J. Richardson, T. Easton, C.J. Higgins, A.M. McDaid, J.A. Hall, C. Calvin, L. Kidane, B.K. Puri, Essential fatty acid deficiency and schizotypal traits, Schizophr. Res. 36 (1999) 108.
13. M.G. Vollema, H. Hoijtink, The multidimensionality of self-report schizotypy in a psychiatric population: an analysis using multidimensional Rasch models, Schizophr. Bull. 26 (2000) 565-575.
14. G.S. Claridge, C. McCreery, O. Mason, The factor structure of schizotypal traits: a large replication study, Br. J. Clin. Psychol. 35 (1996) 103-115.
15. O. Mason, G.S. Claridge, M. Jackson, New scales for the assessment of schizotypy, Personality Individual Differences 18 (1995) 7-13.
16. G.S. Claridge, P. Broks, Schizotypy and hemisphere function. I. Theoretical considerations and the measurement of schizotypy, Personality Individual Differences 5 (1984) 633-648.
17. M.S. Manku, D.F. Horrobin, Y.S. Huang, N. Morse, Fatty acids in plasma and red cell membranes in normal humans, Lipids 18 (1983) 906-908.
18. J.G. Bell, J.R. Sargent, D.R. Tocher, J.R. Dick, Red blood cell fatty acid compositions in a patient with autistic spectrum disorder: a characteristic abnormality in neurodevelopmental disorders? Prostaglandins Leukot. Essent. Fatty Acids 63 (2000) 21-25.
19. J.G. Bell, J.R. Dick, E.E. MacKinlay, A.C.A. Glen, D.J. MacDonald, M.A. Ross, V. Riordan, J.R. Sargent, Apparent fatty acid deficiency in autistic spectrum disorders, Prostaglandins Leukot. Essent. Fatty Acids, in press.
20. M.J. de Alaniz, C.A. Marra, Steroid hormones and fatty acid desaturases, Prostaglandins Leukot. Essent. Fatty Acids 68 (2003) 163-170.
21. A.J. Richardson, T. Easton, B.K. Puri, Red cell and plasma fatty acid changes accompanying symptom remission in a patient with schizophrenia treated with eicosapentaenoic acid, Eur. Neuropsychopharmacol. 10 (2000) 189-193.